74 related articles for article (PubMed ID: 7287679)
1. Comparative studies on the structures of highly active and relatively inactive forms of whale heparin.
Ototani N; Kikuchi M; Yosizawa Z
J Biochem; 1981 Jul; 90(1):241-6. PubMed ID: 7287679
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
Nagasawa K; Uchiyama H
J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-inhibitory activity of whale heparin oligosaccharides.
Ototani N; Kodama C; Kikuchi M; Yosizawa Z
J Biochem; 1984 Dec; 96(6):1695-703. PubMed ID: 6530392
[TBL] [Abstract][Full Text] [Related]
4. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
Ototani N; Kikuchi M; Yosizawa Z
Biochem J; 1982 Jul; 205(1):23-30. PubMed ID: 7126178
[TBL] [Abstract][Full Text] [Related]
5. Separation of heparin into fractions with different anticoagulant activity by hydrophobic interaction chromatography.
Ogamo A; Uchiyama H; Nagasawa K
Biochim Biophys Acta; 1980 Dec; 626(2):477-85. PubMed ID: 7213665
[TBL] [Abstract][Full Text] [Related]
6. The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group.
Lindahl U; Bäckström G; Thunberg L
J Biol Chem; 1983 Aug; 258(16):9826-30. PubMed ID: 6885772
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
Shimotori T; Sakuragawa N
Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909
[TBL] [Abstract][Full Text] [Related]
8. Structure of the antithrombin-binding site in heparin.
Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant activity of heparin octasaccharide.
Ototani N; Yosizawa Z
J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
[TBL] [Abstract][Full Text] [Related]
10. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.
Andrade-Gordon P; Strickland S
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1865-9. PubMed ID: 2106684
[TBL] [Abstract][Full Text] [Related]
11. Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.
Beecher CN; Manighalam MS; Nwachuku AF; Larive CK
Anal Bioanal Chem; 2016 Feb; 408(6):1545-55. PubMed ID: 26758598
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparin.
Bhargava AS; Freihube G; Günzel P
Arzneimittelforschung; 1980; 30(10):1621-3. PubMed ID: 7192096
[TBL] [Abstract][Full Text] [Related]
14. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
Takahashi HK; Nader HB; Dietrich CP
Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
[TBL] [Abstract][Full Text] [Related]
15. Contribution of chemical 6-O-sulfation of the aminodeoxyhexose residues in whale heparin with high affinity for antithrombin III to its anticoagulant properties.
Uchiyama H; Metori A; Ogamo A; Nagasawa K
J Biochem; 1990 Mar; 107(3):377-80. PubMed ID: 2341372
[TBL] [Abstract][Full Text] [Related]
16. An improved method for removal of antithrombin III from post-heparin plasma lipase fractions with a high recovery rate.
Moriguchi EH; Tamachi H; Homma Y; Goto Y
Tokai J Exp Clin Med; 1991 Mar; 16(1):33-41. PubMed ID: 1780907
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of heparin from human mastocytoma tissue.
Thunberg L; Höök M; Lindahl U; Abildgaard U; Langholm R
Thromb Haemost; 1980 Dec; 44(3):125-9. PubMed ID: 6781095
[TBL] [Abstract][Full Text] [Related]
18. Binding of heparin fractions and other polysulfated polysaccharides to plasma fibronectin: effects of molecular size and degree of sulfation of polysaccharides.
Ogamo A; Nagai A; Nagasawa K
Biochim Biophys Acta; 1985 Jul; 841(1):30-41. PubMed ID: 2861857
[TBL] [Abstract][Full Text] [Related]
19. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
Uchiyama H; Fujimoto N; Sakurai K; Nagasawa K
J Chromatogr; 1984 Mar; 287(1):55-66. PubMed ID: 6725457
[TBL] [Abstract][Full Text] [Related]
20. Preparation of biologically active fluorescent heparin composed of fluorescein-labeled species and its behavior to antithrombin III.
Uchiyama H; Nagasawa K
J Biochem; 1981 Jan; 89(1):185-92. PubMed ID: 6783633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
